McKesson Corp. closed 5.19% below its 52-week high of $637.51, which the company reached on August 2nd.

The renewal for the ninth straight year includes McKesson's latest measure for resolution of health-related social needs.

The latest trading session saw McKesson (MCK) ending at $602.95, denoting a -0.24% adjustment from its last day's close. The stock fell short of the S&P 500, which registered a gain of 0.92% for the ...

ONWARD ARC-EX System for spinal cord injury is now available for purchase through VA Federal Supply Schedule and GSA Advantage ...

After hours: January 24 at 7:59:35 PM EST ...

Medical research involves research in a wide range of fields, such as biology, chemistry, pharmacology and toxicology with the goal of developing new medicines or medical procedures or improving ...

A good hook can draw listeners in, but bad sound quality can drive them away. From mics to headphones, here’s the best podcast gear we’ve tested for recording professional-quality audio. I've ...

Researchers at the University of Colorado Anschutz Medical Campus have found a promising drug candidate that could help restore vision in individuals with multiple sclerosis (MS) and other ...

The State of Idaho and Boise State University have an extensive group of contracts and agreements. The use of these contracts is required when purchases are made by the university and must be used ...

Jan. 27, 2025 — Infant mortality in the United States decreased by 24.2% between 1999 and 2022. However, mortality rates from Sudden Unexpected Infant Death (SUID) rose significantly -- by 11.8% ...

Unlock the potential of GLP-1 therapies! Join experts to explore cutting-edge strategies for managing cardiovascular & endocrine cases. Enhance outcomes for complex patients with actionable insights.